BDX Becton, Dickinson and Company
BDX Becton, Dickinson and Company
Healthcare · Medical Instruments & Supplies
Market read
POC $146.50 · VWAP $153.19 · +18.9% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
BDX Price Structure
Loading timeframes…
Peers
Every watchlist BDX belongs to, members best 30-day change first — BDX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@trace-glp1-manufacturing
Reported the quarter ending 2026-03-31: revenue $4.71B, diluted EPS $-1.11, net income $-311M (SEC filing). Across the print the stock moved +3.2% (close before → first close after).
full note →Against street estimates
How BDX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
BDX research tape
2 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.